menu
    • menu

    Company profile for Connoya Biomedical Technology

    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Connoya Biomedical Technology Co., Ltd. (2162.HK) is based on innovation, focusing on research and development, and is committed to providing patients with more high-quality and affordable innovative therapies, and creating Noah's Ark for health escort. Focusing on the inventors of the first and approved PD-1 antibody drugs in the world and China, the leadership team is all top experts in the biopharmaceutical industry, with w...
    Connoya Biomedical Technology Co., Ltd. (2162.HK) is based on innovation, focusing on research and development, and is committed to providing patients with more high-quality and affordable innovative therapies, and creating Noah's Ark for health escort. Focusing on the inventors of the first and approved PD-1 antibody drugs in the world and China, the leadership team is all top experts in the biopharmaceutical industry, with world-class rich scientific and technological achievements transformation and excellent domestic and foreign industrialization experience.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Connoya Biomedical TechnologyChina Flag
    Country
    Country
    China
    Address
    Address
    Building D2, Tianfu International Biological City, Shuangliu
    Telephone
    Telephone
    028-88610620
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.keymedbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results
    Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results

    27 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/keymed-biosciences-02162hk-reports-strong-interim-2025-results-with-accelerated-commercialization-and-robust-rd-momentum-302539775.html

    PR NEWSWIRE
    27 Aug 2025
    Share Share
    Keymed Biosciences Announces Latest CM336 Trial Results in NEJM
    Keymed Biosciences Announces Latest CM336 Trial Results in NEJM

    13 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/keymed-biosciences-announces-the-latest-clinical-trial-results-of-cm336-published-in-the-new-england-journal-of-medicine-302481042.html

    PR NEWSWIRE
    13 Jun 2025
    Share Share
    Keymed Biosciences gets IND approval for CM518D1 by China's NMPA
    Keymed Biosciences gets IND approval for CM518D1 by China's NMPA

    25 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/keymed-biosciences-announces-approval-of-ind-for-cm518d1-by-the-national-medical-products-administration-of-china-for-the-treatment-of-solid-tumors-302438259.html

    PR NEWSWIRE
    25 Apr 2025
    Share Share
    Keymed gets IND approval for CM518D1 in China for Gastro Cancers
    Keymed gets IND approval for CM518D1 in China for Gastro Cancers

    24 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/keymed-biosciences-announces-approval-of-ind-for-cm518d1-by-the-national-medical-products-administration-of-china-for-the-treatment-of-gastrointestinal-cancers-302438097.html

    PR NEWSWIRE
    24 Apr 2025
    Share Share
    Keymed Biosciences Announces Annual Results of 2024
    Keymed Biosciences Announces Annual Results of 2024

    26 Mar 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/keymed-biosciences-announces-annual-results-of-2024-302412143.html

    PR NEWSWIRE
    26 Mar 2025
    Share Share
    Keymed Stapokibart Approved For Seasonal Allergic Rhinitis
    Keymed Stapokibart Approved For Seasonal Allergic Rhinitis

    07 Feb 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/keymed-biosciences-announces-approval-of-stapokibart-for-the-treatment-of-seasonal-allergic-rhinitis-302371670.html

    PR NEWSWIRE
    07 Feb 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search